312365
Doing Prevention in the ACA Era: CBOs in the Midwest Finding Their Way
Methods: In-depth interviews were conducted with executive administrators of 11 different CBOs in the Midwest. Interviews explored how each CBO has integrated behavioral and biomedical prevention methods, as well as the challenges and opportunities presented by the ACA. Thematic transcript analysis was conducted to identify common insights and challenges experienced by respondents.
Results: Most interviewees indicated that their prevention efforts were not directly facilitated by ACA. Many identified challenges with integrating biomedical interventions. Cited challenges included lack of frontline staff knowledge and ethical concerns regarding PrEP and PEP. Interviewees also described a prevention environment where acceptable interventions are prescribed by funders, who place heavy emphasis on “test and treat” strategies over other behavioral and biomedical approaches.
Conclusions: The ACA offers a potential opportunity to curb the tide of HIV within high-risk populations. To be successful, new frameworks must be developed for strategically integrating interventions and for evaluating their combined effect. Future research in this area should explore how expanded access to healthcare provided by the ACA will impact acceptability and uptake of biomedical prevention strategies, and work with CBOs to determine effective strategies for engaging and retaining high-risk individuals in these interventions.
Learning Areas:
Chronic disease management and preventionImplementation of health education strategies, interventions and programs
Planning of health education strategies, interventions, and programs
Public health administration or related administration
Learning Objectives:
Identify and describe the challenges and opportunities facing community-based organizations conducting HIV-prevention activities in the Affordable Care Act era.
Keyword(s): Community-Based Health, HIV Interventions
Qualified on the content I am responsible for because: Prior to my pursuit of a PhD, I served as program director for a federally funded study designed to explore the acceptability and feasibility of pre-exposure prophylaxis among young MSM. I also served as director of federal affairs for the AIDS Foundation of Chicago, where I worked on implementation of the National AIDS Strategy in Illinois. My primary focus as a doctoral student is on the integration of behavioral and biomedical HIV prevention strategies.
Any relevant financial relationships? No
I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.